Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated muc1 glycopeptides and the toll-like receptor 2 agonist pam3CysSer

Brendan L. Wilkinson, Stephanie Day, Lara R. Malins, Vasso Apostolopoulos, Richard J. Payne

Research output: Contribution to journal › Article › peer-review

139 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated muc1 glycopeptides and the toll-like receptor 2 agonist pam3CysSer'. Together they form a unique fingerprint.

Immunology and Microbiology

Biochemistry, Genetics and Molecular Biology